Enhanced Everolimus Delivery: Development and Evaluation of a Nanosuspension Formulation
These findings indicate that EV-sus might be an effective therapy for corneal neovascularization. The formulation exhibits excellent biocompatibility, efficient cellular uptake, and robust anti-angiogenic activity, suggesting its suitability for ocular administration and the potential to mitigate CNV progression with minimal irritation.
Authors
- Zhan Tang (ORCID: https://orcid.org/0000-0002-3198-3690)
- Haonan Xu
- Qiao Zeng
- Jie Chen (ORCID: https://orcid.org/0000-0002-6134-6246)
- Qiao Wang (ORCID: https://orcid.org/0000-0003-0648-9399)
- Han Zhang
- Wenying Yu
Institutions
- Hangzhou Medical College (CN)
Publication Details
- Journal
- International Journal of Nanomedicine
- Published
- 2025-12-01
- DOI
- https://doi.org/10.2147/ijn.s562002
- Primary Topic
- Advanced Drug Delivery Systems
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Department of Education of Zhejiang Province